Stay updated on Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.

Latest updates to the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check66 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
Stay in the know with updates to Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.